Find a Tender
complete
Published value
Not published
Submission deadline Not published
Lots published35
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority"): "Oncology Generics Medicines". Published status: complete. Published value: Value not published. 35 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority"). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
4.3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 151 active published awards; 151 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published5 Feb 2021, 12:40 GMT | Last source update5 Feb 2021, 12:40 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-029095 | ||
What is being bought
This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland.
The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”.
Full details of each Lot is contained in section II.2 of this notice.
What changed
From the official release history
- Status changed to complete
5 Feb 2021, 12:40 GMT - Official notice release published
5 Feb 2021, 12:40 GMT - Buyer information updated
5 Feb 2021, 12:40 GMT
Lots and requirements (35)
Published by the contracting authority
- Lot 1 · #1Lot 1 Bendamustine Powder For Solution For InfusioncancelledPublished valueNot publishedSupply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #10Lot 10 Doxorubicin Hydrochloride InjectionscancelledPublished valueNot publishedSupply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #11Lot 11 ImatinibcancelledPublished valueNot publishedThe supply of Imatinib to NHS Scotland. The Authority has awarded each product line as a ranked multi-supplier ranked framework agreement to seven (7) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #12Lot 12 Etoposide InjectioncancelledPublished valueNot publishedSupply of Etoposide Injection to NHS Scotland. The Authority has awarded award this Lot as a ranked multi-supplier framework to three (3) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #13Lot 13 Fluorouracil 25MG/ML InjectioncancelledPublished valueNot publishedSupply of Fluorouracil 25MG/ML Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 6 · #14Lot 14 Fluorouracil 50MG/ML InjectioncancelledPublished valueNot publishedSupply of Fluorouracil 50MG/ML Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 7 · #15Lot 15 Gemcitabine 38MG/ML Concentrate For Solution For Infusion VialscancelledPublished valueNot publishedSupply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 8 · #16Lot 16 Gemcitabine 100MG/ML Concentrate For Solution For Infusion VialscancelledPublished valueNot publishedSupply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 9 · #18Lot 18 Idarubicin Hydrochlioride Injection Powder For ReconstitutioncancelledPublished valueNot publishedSupply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 10 · #19Lot 19 Ifosfamide Injection Powder For ReconstitutioncancelledPublished valueNot publishedSupply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 11 · #2Lot 2 Capecitabine TabletscancelledPublished valueNot publishedSupply of Capecitabine Tablets to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 12 · #20Lot 20 Irinotecan Hydrochloride InjectioncancelledPublished valueNot publishedSupply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 13 · #21Lot 21 Lanreotide Injection Prefilled SyringescancelledPublished valueNot publishedSupply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 14 · #22Lot 22 Methotrexate Without Preservatives InjectioncancelledPublished valueNot publishedSupply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 15 · #23Lot 23 Methotrexate Oral SolutioncancelledPublished valueNot publishedSupply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 16 · #25Lot 25 Oxaliplatin Vial SolutioncancelledPublished valueNot publishedSupply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 17 · #26Lot 26 Paclitaxel Concentrate For Intravenous InfusioncancelledPublished valueNot publishedSupply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 18 · #27Lot 27 Temozolomide CapsulescancelledPublished valueNot publishedSupply of Temozolomide Capsules to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 19 · #28Lot 28 Vincristine Without Preservatives InjectioncancelledPublished valueNot publishedSupply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 20 · #29Lot 29 Vinorelbine InjectioncancelledPublished valueNot publishedSupply of Vinorelbine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 21 · #3Lot 3 Carboplatin InjectioncancelledPublished valueNot publishedSupply of Carboplatin Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 22 · #30Lot 30 Octreotide Vials Long Acting (Excluding Homecare)cancelledPublished valueNot publishedSupply of octreotide vials long acting(excluding homecare) to NHS Scotland The Authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) Framework participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 23 · #31Lot 31 Octreotide Vials Long Acting (Including Homecare)cancelledPublished valueNot publishedSupply of octreotide vials long acting(including homecare) to NHS Scotland. The Authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) Framework participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 24 · #33Lot 33 PEGFILGRASTIM 6MG PRE-FILLED SYRINGEcancelledPublished valueNot publishedSupply of pegfilgrastim 6mg pre-filled syringe to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier Framework to three (3) Framework Participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 25 · #34Lot 34 APREPITANT CAPSULEScancelledPublished valueNot publishedSupply of aprepitant capsules to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 26 · #36Lot 36 TOPOTECAN CONCENTRATE FOR SOLUTION FOR INFUSIONcancelledPublished valueNot publishedSupply of topotecan concentrate for solution for infusion to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 27 · #37Lot 37 OCTREOTIDE INJECTIONcancelledPublished valueNot publishedSupply of Octreotide Injection The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 28 · #38Lot 38 Filgrastim Pre-Filled SyringecancelledPublished valueNot publishedSupply of Filgrastim Pre-Filled Syringe to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 29 · #39Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONScancelledPublished valueNot publishedSupply of all other products/presentations within this tender to NHS Scotland. Each product line was treated as an individual Lot, and has been awarded to a single supplier Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 30 · #4Lot 4 Cisplatin InjectioncancelledPublished valueNot publishedSupply of Cisplatin Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 31 · #5Lot 5 Cyclophosphamide Injection, Powder For ReconstitutioncancelledPublished valueNot publishedSupply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 32 · #6Lot 6 Cytarabine InjectionscancelledPublished valueNot publishedSupply of Cytarabine Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 33 · #7Lot 7 Dacarbazine InjectionscancelledPublished valueNot publishedSupply of Dacarbazine Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 34 · #8Lot 8 Disodium Folinate InjectioncancelledPublished valueNot publishedSupply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 35 · #9Lot 9 Docetaxel Concentrate For Solution For InfusioncancelledPublished valueNot publishedSupply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
5 Feb 2021, 12:40 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 16 Dec 2020, 00:00 GMT · £788,004 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £172,585 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £47,136 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £256,048 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £311,548 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £27,066 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £11,635 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £99,636 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £1,836,044 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £211,502 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £5,329,440 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £501,334 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £301,276 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £122,640 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £135,558 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £235,290 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £130,179 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £73,388 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £53,200 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £3,258,010 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £50,148 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £242,580 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £97,798 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £80,939 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £29,040 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £146,415 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £1,150,475 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £11,880,219 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £173,904 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £97,338 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £236,452 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £342,260 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £250,754 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £61,752 - Contract active
Signed 16 Dec 2020, 00:00 GMT · £340,708
Commercial outcome and competition
Awards Waverley Pharma Europe Limited Not published · Not published · active Accord Healthcare Ltd, Fresenius Kabi Limited, medac Pharma LLP Not published · Not published · active Pfizer Ltd Not published · Not published · active medac Pharma LLP Not published · Not published · active Accord Healthcare Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Accord Healthcare Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Baxter Healthcare Ltd Not published · Not published · active Fresenius Kabi Limited Not published · Not published · active Ipsen Limited Not published · Not published · active Consilient Health Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Rosemont Pharmaceuticals Ltd Not published · Not published · active Ranbaxy (UK) Ltd Not published · Not published · active Fresenius Kabi Limited Not published · Not published · active Accord Healthcare Ltd Not published · Not published · active Teva UK Limited Not published · Not published · active medac Pharma LLP Not published · Not published · active Novartis Pharmaceuticals UK Ltd, Teva UK Limited Not published · Not published · active Novartis Pharmaceuticals UK Ltd, Teva UK Limited Not published · Not published · active Accord Healthcare Ltd, Napp Pharmaceuticals, Sandoz Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Zentiva Pharma UK Ltd Not published · Not published · active Accord Healthcare Ltd Not published · Not published · active Ranbaxy (UK) Ltd Not published · Not published · active Accord Healthcare Ltd Not published · Not published · active Accord Healthcare Ltd, Altan Pharma Ltd., Aspen Pharmacare UK Limited, Baxter Healthcare Ltd, Consilient Health Ltd, DRUGSRUS LTD, Dr Reddy's Laboratories (UK) Ltd, Fresenius Kabi Limited, Glenmark Pharmaceuticals Europe Ltd, Ipsen Limited, Kent Pharmaceuticals Ltd, Martindale Pharma, Morningside Pharmaceuticals Limited, Mylan, Pfizer Ltd, Ranbaxy (UK) Ltd, Rosemont Pharmaceuticals Ltd, Sandoz Ltd, Selective Supplies Ltd, Teva UK Limited, Tillomed Laboratories ltd, hameln pharmaceuticals ltd, medac Pharma LLP Not published · Not published · active Sandoz Ltd Not published · Not published · active Accord Healthcare Ltd Not published · Not published · active medac Pharma LLP Not published · Not published · active medac Pharma LLP Not published · Not published · active Accord Healthcare Ltd Not published · Not published · active medac Pharma LLP Not published · Not published · active Accord Healthcare Ltd, Dr Reddy's Laboratories (UK) Ltd, Neon Healthcare Ltd, Novartis Pharmaceuticals UK Ltd, Sandoz Ltd, Teva UK Limited, Zentiva Pharma UK Ltd Not published · Not published · active |
Contracts Lot 2 Capecitabine Tablets £788,004 · signed 16 Dec 2020, 00:00 GMT · active Lot 12 Etoposide Injection £172,585 · signed 16 Dec 2020, 00:00 GMT · active Lot 13 Fluorouracil 25MG/ML Injection £47,136 · signed 16 Dec 2020, 00:00 GMT · active Lot 14 Fluorouracil 50MG/ML Injection £256,048 · signed 16 Dec 2020, 00:00 GMT · active Lot 1 Bendamustine Powder For Solution For Infusion £311,548 · signed 16 Dec 2020, 00:00 GMT · active Lot 15 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials £27,066 · signed 16 Dec 2020, 00:00 GMT · active Lot 16 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials £11,635 · signed 16 Dec 2020, 00:00 GMT · active Lot 18 Idarubicin Hydrochlioride Injection Powder For Reconstitution £99,636 · signed 16 Dec 2020, 00:00 GMT · active Lot 19 Ifosfamide Injection Powder For Reconstitution £1,836,044 · signed 16 Dec 2020, 00:00 GMT · active Lot 20 Irinotecan Hydrochloride Injection £211,502 · signed 16 Dec 2020, 00:00 GMT · active Lot 21 Lanreotide Injection Prefilled Syringes £5,329,440 · signed 16 Dec 2020, 00:00 GMT · active Lot 3 Carboplatin Injection £501,334 · signed 16 Dec 2020, 00:00 GMT · active Lot 22 Methotrexate Without Preservatives Injection £301,276 · signed 16 Dec 2020, 00:00 GMT · active Lot 23 Methotrexate Oral Solution £122,640 · signed 16 Dec 2020, 00:00 GMT · active Lot 25 Oxaliplatin Vial Solution £135,558 · signed 16 Dec 2020, 00:00 GMT · active Lot 26 Paclitaxel Concentrate For Intravenous Infusion £235,290 · signed 16 Dec 2020, 00:00 GMT · active Lot 27 Temozolomide Capsules £130,179 · signed 16 Dec 2020, 00:00 GMT · active Lot 28 Vincristine Without Preservatives Injection £73,388 · signed 16 Dec 2020, 00:00 GMT · active Lot 29 Vinorelbine Injection £53,200 · signed 16 Dec 2020, 00:00 GMT · active Lot 30 Octreotide Vials Long Acting (Excluding Homecare) £3,258,010 · signed 16 Dec 2020, 00:00 GMT · active Lot 31 Octreotide Vials Long Acting (Including Homecare) £50,148 · signed 16 Dec 2020, 00:00 GMT · active Lot 33 PEGFILGRASTIM 6MG PRE-FILLED SYRINGE £242,580 · signed 16 Dec 2020, 00:00 GMT · active Lot 4 Cisplatin Injection £97,798 · signed 16 Dec 2020, 00:00 GMT · active Lot 34 APREPITANT CAPSULES £80,939 · signed 16 Dec 2020, 00:00 GMT · active Lot 36 TOPOTECAN CONCENTRATE FOR SOLUTION FOR INFUSION £29,040 · signed 16 Dec 2020, 00:00 GMT · active Lot 37 OCTREOTIDE INJECTION £146,415 · signed 16 Dec 2020, 00:00 GMT · active Lot 38 Filgrastim Pre-Filled Syringe £1,150,475 · signed 16 Dec 2020, 00:00 GMT · active Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS £11,880,219 · signed 16 Dec 2020, 00:00 GMT · active Lot 5 Cyclophosphamide Injection, Powder For Reconstitution £173,904 · signed 16 Dec 2020, 00:00 GMT · active Lot 6 Cytarabine Injections £97,338 · signed 16 Dec 2020, 00:00 GMT · active Lot 7 Dacarbazine Injections £236,452 · signed 16 Dec 2020, 00:00 GMT · active Lot 8 Disodium Folinate Injection £342,260 · signed 16 Dec 2020, 00:00 GMT · active Lot 9 Docetaxel Concentrate For Solution For Infusion £250,754 · signed 16 Dec 2020, 00:00 GMT · active Lot 10 Doxorubicin Hydrochloride Injections £61,752 · signed 16 Dec 2020, 00:00 GMT · active Lot 11 Imatinib £340,708 · signed 16 Dec 2020, 00:00 GMT · active |
Bid statistics bids: 5 (lot 1) electronicBids: 5 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) smeBids: 0 (lot 1) bids: 2 (lot 10) electronicBids: 2 (lot 10) foreignBidsFromEU: 0 (lot 10) foreignBidsFromNonEU: 0 (lot 10) smeBids: 0 (lot 10) bids: 7 (lot 11) electronicBids: 7 (lot 11) foreignBidsFromEU: 0 (lot 11) foreignBidsFromNonEU: 0 (lot 11) smeBids: 0 (lot 11) bids: 3 (lot 12) electronicBids: 3 (lot 12) foreignBidsFromEU: 0 (lot 12) foreignBidsFromNonEU: 0 (lot 12) smeBids: 0 (lot 12) bids: 1 (lot 13) electronicBids: 1 (lot 13) foreignBidsFromEU: 0 (lot 13) foreignBidsFromNonEU: 0 (lot 13) smeBids: 0 (lot 13) bids: 2 (lot 14) electronicBids: 2 (lot 14) foreignBidsFromEU: 0 (lot 14) foreignBidsFromNonEU: 0 (lot 14) smeBids: 0 (lot 14) bids: 2 (lot 15) electronicBids: 2 (lot 15) foreignBidsFromEU: 0 (lot 15) foreignBidsFromNonEU: 0 (lot 15) smeBids: 0 (lot 15) bids: 2 (lot 16) electronicBids: 2 (lot 16) foreignBidsFromEU: 0 (lot 16) foreignBidsFromNonEU: 0 (lot 16) smeBids: 0 (lot 16) bids: 1 (lot 18) electronicBids: 1 (lot 18) foreignBidsFromEU: 0 (lot 18) foreignBidsFromNonEU: 0 (lot 18) smeBids: 0 (lot 18) bids: 2 (lot 19) electronicBids: 2 (lot 19) foreignBidsFromEU: 0 (lot 19) foreignBidsFromNonEU: 0 (lot 19) smeBids: 0 (lot 19) bids: 6 (lot 2) electronicBids: 6 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) smeBids: 0 (lot 2) bids: 6 (lot 20) electronicBids: 6 (lot 20) foreignBidsFromEU: 0 (lot 20) foreignBidsFromNonEU: 0 (lot 20) smeBids: 0 (lot 20) bids: 1 (lot 21) electronicBids: 1 (lot 21) foreignBidsFromEU: 0 (lot 21) foreignBidsFromNonEU: 0 (lot 21) smeBids: 0 (lot 21) bids: 2 (lot 22) electronicBids: 2 (lot 22) foreignBidsFromEU: 0 (lot 22) foreignBidsFromNonEU: 0 (lot 22) smeBids: 0 (lot 22) bids: 1 (lot 23) electronicBids: 1 (lot 23) foreignBidsFromEU: 0 (lot 23) foreignBidsFromNonEU: 0 (lot 23) smeBids: 0 (lot 23) bids: 3 (lot 25) electronicBids: 3 (lot 25) foreignBidsFromEU: 0 (lot 25) foreignBidsFromNonEU: 0 (lot 25) smeBids: 0 (lot 25) bids: 3 (lot 26) electronicBids: 3 (lot 26) foreignBidsFromEU: 0 (lot 26) foreignBidsFromNonEU: 0 (lot 26) smeBids: 0 (lot 26) bids: 4 (lot 27) electronicBids: 4 (lot 27) foreignBidsFromEU: 0 (lot 27) foreignBidsFromNonEU: 0 (lot 27) smeBids: 0 (lot 27) bids: 2 (lot 28) electronicBids: 2 (lot 28) foreignBidsFromEU: 0 (lot 28) foreignBidsFromNonEU: 0 (lot 28) smeBids: 0 (lot 28) bids: 1 (lot 29) electronicBids: 1 (lot 29) foreignBidsFromEU: 0 (lot 29) foreignBidsFromNonEU: 0 (lot 29) smeBids: 0 (lot 29) bids: 3 (lot 3) electronicBids: 3 (lot 3) foreignBidsFromEU: 0 (lot 3) foreignBidsFromNonEU: 0 (lot 3) smeBids: 0 (lot 3) bids: 2 (lot 30) electronicBids: 2 (lot 30) foreignBidsFromEU: 0 (lot 30) foreignBidsFromNonEU: 0 (lot 30) smeBids: 0 (lot 30) bids: 2 (lot 31) electronicBids: 2 (lot 31) foreignBidsFromEU: 0 (lot 31) foreignBidsFromNonEU: 0 (lot 31) smeBids: 0 (lot 31) bids: 3 (lot 33) electronicBids: 0 (lot 33) foreignBidsFromEU: 0 (lot 33) foreignBidsFromNonEU: 0 (lot 33) smeBids: 0 (lot 33) bids: 4 (lot 34) electronicBids: 4 (lot 34) foreignBidsFromEU: 0 (lot 34) foreignBidsFromNonEU: 0 (lot 34) smeBids: 0 (lot 34) bids: 2 (lot 36) electronicBids: 2 (lot 36) foreignBidsFromEU: 0 (lot 36) foreignBidsFromNonEU: 0 (lot 36) smeBids: 0 (lot 36) bids: 4 (lot 37) electronicBids: 4 (lot 37) foreignBidsFromEU: 0 (lot 37) foreignBidsFromNonEU: 0 (lot 37) smeBids: 0 (lot 37) bids: 3 (lot 38) electronicBids: 3 (lot 38) foreignBidsFromEU: 0 (lot 38) foreignBidsFromNonEU: 0 (lot 38) smeBids: 0 (lot 38) bids: 35 (lot 39) electronicBids: 35 (lot 39) foreignBidsFromEU: 0 (lot 39) foreignBidsFromNonEU: 0 (lot 39) smeBids: 0 (lot 39) bids: 3 (lot 4) electronicBids: 3 (lot 4) foreignBidsFromEU: 0 (lot 4) foreignBidsFromNonEU: 0 (lot 4) smeBids: 0 (lot 4) bids: 2 (lot 5) electronicBids: 2 (lot 5) foreignBidsFromEU: 0 (lot 5) foreignBidsFromNonEU: 0 (lot 5) smeBids: 0 (lot 5) bids: 2 (lot 6) electronicBids: 2 (lot 6) foreignBidsFromEU: 0 (lot 6) foreignBidsFromNonEU: 0 (lot 6) smeBids: 0 (lot 6) bids: 1 (lot 7) electronicBids: 1 (lot 7) foreignBidsFromEU: 0 (lot 7) foreignBidsFromNonEU: 0 (lot 7) smeBids: 0 (lot 7) bids: 1 (lot 8) electronicBids: 1 (lot 8) foreignBidsFromEU: 0 (lot 8) foreignBidsFromNonEU: 0 (lot 8) smeBids: 0 (lot 8) bids: 2 (lot 9) electronicBids: 2 (lot 9) foreignBidsFromEU: 0 (lot 9) foreignBidsFromNonEU: 0 (lot 9) smeBids: 0 (lot 9) |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Contracting authority GB-FTS-4546Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published